21 CFR 876.1300
§ 876.1300 Ingestible telemetric gastrointestinal capsule imaging system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 876.1300, § 876.1300 Ingestible telemetric gastrointestinal capsule imaging system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/90272
- Permanent ID
ys:prov:90272@1- SHA-256
5a39e022c5e7aabf348c3ec7e6d924d556bcccdc6155e4ec40d77b8ec1ed5ff0
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. An ingestible telemetric gastrointestinal capsule imaging system is used for visualization of the small bowel mucosa as an adjunctive tool in the detection of abnormalities of the small bowel. The device captures images of the small bowel with a wireless camera contained in a capsule. This device includes an ingestible capsule (containing a light source, camera, transmitter, and battery), an antenna array, a receiving/recording unit, a data storage device, computer software to process the images, and accessories.
(b) Classification. Class II (special controls). The special control is FDA's guidance, “Class II Special Controls Guidance Document: Ingestible Telemetric Gastrointestinal Capsule Imaging Systems; Final Guidance for Industry and FDA.”
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.